CLINICAL_TRIALS
trial_result
· 2026-04-02
Clinical Trial Update: A Study of Full Treatment-free Remission in Patients With Chronic Myeloid Leukemia [Phase 2]
Summary
Phase 2 study in chronic myeloid leukemia evaluating full treatment-free remission has completed and results are reported.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Myeloid Leukemia | Phase 2 | Status: COMPLETED